Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro
Health care delivery experts say patients in the U.S. need more help dealing with a system that is growing increasingly complex
Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice
Patients can now see a growing array of doctors without leaving their living room recliner thanks to telemedicine
The Biden administration is pushing to prevent medical debt from being considered in most decisions made over whether someone qualifies to rent an apartment, buy a car or take on a mortgage
Erin Fox has tracked drug shortages for more than 20 years, and she sees no easy solutions for what has become a record run
Walgreens is finalizing a plan to fix its business that could result in the closure of hundreds of additional stores in the next three years
UnitedHealth topped second-quarter forecasts but remains cautious about the year as it continues to eat costs from a massive cyberattack and deal with rising medical expenses
No, you don't really have to wait 30 minutes after eating to go swimming
Shares of Biogen slid Friday after a European regulatory committee said the Alzheimer’s treatment Leqembi should not receive marketing approval
America’s drugstores are testing smaller locations and more ways to offer care as more store closings loom
CVS Health has chopped its 2024 forecast for a third time as the health care giant continues to struggle with high utilization in its health insurance business
Eli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight loss counterpart Zepbound funneling more than $4 billion in sales to the drugmaker
Some cancer patients are hitting coverage limits on a cheap anti-nausea pill that can ward off waves of vomiting after treatment
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients
Thinner benefits and coverage changes await many older Americans shopping for health insurance this fall
Shopping season for Medicare coverage is about to begin and with it comes the annual onslaught of TV ads and choices to consider
Experts say the fallout from storm damage to a North Carolina factory that makes critical hospital supplies will be felt broadly and could linger
A Florida factory that makes IV fluids critical to hospitals nationwide will restart after shutting down while Hurricane Milton tore through the state
A nonprofit finds in a recent survey that large employers expect the cost to treat patients will jump nearly 8% next year
Walgreens is planning to close around 1,200 locations, as the drugstore chain and its rivals struggle to define their role for U.S. shoppers who no longer look to them first for convenience
Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its third quarter
CVS Health CEO Karen Lynch has stepped down with company shares sinking 19% this year and the health care giant struggling on several fronts
Surgery schedules around the country may be washed out for several more weeks while a crucial IV and sterile fluids factory remains closed after a hurricane-related shutdown
A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year
Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
